Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Rigosertib [USAN:INN]
RN: 592542-59-1
UNII: 67DOW7F9GL
InChIKey: OWBFCJROIKNMGD-BQYQJAHWSA-N

Note

  • A Plk1 inhibitor with antineoplastic activity.M

    NCI: A synthetic benzyl styryl sulfone analogue with potential antineoplastic activity. Rigosertib sodium inhibits polo-like kinase1 (Plk1), inducing selective G2/M arrest followed by apoptosis in a variety of tumor cells while causing reversible cell arrest at the G1 and G2 stage without apoptosis in normal cells. This agent may exhibit synergistic antitumor activity in combination with other chemotherapeutic agents. Plk1, named after the polo gene of Drosophila melanogaster, is a serine/threonine protein kinase involved in regulating mitotic spindle function in a non-ATP competitive manner. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Molecular Formula

  • C21-H25-N-O8-S

Molecular Weight

  • 451.4935
 

Classification Code

  • Antineoplastic
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Rigosertib [USAN:INN]

Synonyms

  • N-(2-Methoxy-5-((((1E)-2-(2,4,6-trimethoxyphenyl)ethenyl)sulfonyl)methyl) phenyl)glycine
  • ON 01910
  • Rigosertib
  • UNII-67DOW7F9GL

Systematic Name

  • Glycine, N-(2-methoxy-5-((((1E)-2-(2,4,6-trimethoxyphenyl)ethenyl)sulfonyl) methyl)phenyl)-

Registry Numbers

CAS Registry Number

  • 592542-59-1

FDA UNII

  • 67DOW7F9GL

System Generated Number

  • 0592542591

Structure Descriptors

InChI

1S/C21H25NO8S/c1-27-15-10-19(29-3)16(20(11-15)30-4)7-8-31(25,26)13-14-5-6-18(28-2)17(9-14)22-12-21(23)24/h5-11,22H,12-13H2,1-4H3,(H,23,24)/b8-7+

InChIKey

OWBFCJROIKNMGD-BQYQJAHWSA-N

Smiles

COc1ccc(cc1NCC(=O)O)CS(=O)(=O)/C=C/c2c(cc(cc2OC)OC)OC